Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Timothy Ekpo

Adult Reconstructive Orthopaedic Surgery Grand Blanc, MI Doctor of Osteopathy

NPI 1891003240 CMS profile 176910

12303 Pinehurst Ln, Grand Blanc, MI 48439

Open in the dashboard

General payments

$294,598

272 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Timothy Ekpo of Grand Blanc, MI is reported in the CMS Open Payments database as having received $294,598 across 272 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $62,912 35
2024 General $84,968 59
2023 General $45,681 38
2022 General $14,397 20
2021 General $30,924 39
2020 General $33,715 30
2019 General $22,000 51

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Timothy Ekpo
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Timothy Ekpo were reported at $62,912. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Timothy Ekpo Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $22,000 $1,416 $292–$9,336 $163
2020 $33,715 $647 $141–$6,474 $114
2021 $30,924 $1,073 $211–$6,497 $132
2022 $14,397 $1,217 $236–$6,299 $149
2023 $45,681 $1,082 $246–$6,818 $160
2024 $84,968 $1,575 $323–$8,944 $164
2025 $62,912 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Encore Medical, LP $170,376 96 payments
  2. Zimmer Biomet Holdings, Inc. $63,082 81 payments
  3. Medtronic USA, Inc. $19,919 14 payments
  4. Insight Medical Systems, Inc. $13,783 18 payments
  5. Smith+Nephew, Inc. $13,267 41 payments
  6. Medtronic, Inc. $10,191 11 payments
  7. Uoc USA Inc $2,628 7 payments
  8. Ortho Development Corporation $986 1 payment
  9. Bioventus LLC $237 1 payment
  10. Abbott Laboratories $127 1 payment
  11. Other $2 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $234,513 117 payments
  2. Travel and Lodging $29,032 76 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $27,370 9 payments
  4. Food and Beverage $3,683 70 payments
Products named General payments · program years 2019–2025
  1. DJO SURGICAL Joint Implants $81,016 39 payments
  2. DJO SURGICAL Joint Implants $33,395 14 payments
  3. ROSA-Knee Knees $22,501 24 payments
  4. AQUAMANTYS $18,918 11 payments
  5. Arvis $13,783 18 payments
  6. ROSA-Knee Knees $11,302 14 payments
  7. DJO SURGICAL Joint Implants $9,637 14 payments
  8. Journey II BCS $8,294 7 payments
  9. Journey II CR $8,294 7 payments
  10. Legion $8,234 6 payments
  11. Other $41,309 85 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

44

Median for Orthopedic Surgery: 203

Drug cost

$390

Median for Orthopedic Surgery: $1,433

Branded share of claims

75%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 21 $195
Diclofenac Sodium Generic 11 $114
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 12 $82

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 24 billing codes

Paid by Medicare

$27,139

Medicare's payments for the services billed

Medicare patients

200

Average age 74

Services billed

484

140 women, 60 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Depression 26%
Diabetes 25%
Ischemic heart disease 25%
Chronic kidney disease 20%
Atrial fibrillation 16%
COPD 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

272 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record